Allergan Loses a Patent Battle…Has It Lost the War? By: Stocks to Watch October 16, 2017 at 15:35 PM EDT Shares of Allergan are falling after a federal judge invalidated patents covering the dry eye drug Restasis. Here's what's next for the drug maker. Read More >> Related Stocks: Teva Pharmaceutical Industries ADR
